Enfortumab vedotin Interactions
There are 477 drugs known to interact with enfortumab vedotin, along with 3 disease interactions. Of the total drug interactions, 76 are major, 352 are moderate, and 49 are minor.
- View all 477 medications that may interact with enfortumab vedotin
- View enfortumab vedotin disease interactions (3)
Most frequently checked interactions
View interaction reports for enfortumab vedotin and the medicines listed below.
- Aspir 81 (aspirin)
- Benadryl (diphenhydramine)
- Benefiber Powder (wheat dextrin)
- Bystolic (nebivolol)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- D3 (cholecalciferol)
- Dulcolax Stool Softener (docusate)
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Lyrica (pregabalin)
- Maxzide (hydrochlorothiazide / triamterene)
- Medrol Dosepak (methylprednisolone)
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Mucinex (guaifenesin)
- Myrbetriq (mirabegron)
- One Tab Daily (multivitamin)
- OxyContin (oxycodone)
- Protonix (pantoprazole)
- Senokot (senna)
- Tylenol (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Enfortumab vedotin disease interactions
There are 3 disease interactions with enfortumab vedotin which include:
Report options
More about enfortumab vedotin
- enfortumab vedotin consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Cisplatin
Cisplatin systemic is used for anal cancer, bladder cancer, blood cell transplantation, bone marrow ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
